The disposition of morphine and morphine-3-glucuronide in the isolated perfused rat liver: Effects of altered perfusate flow

被引:7
|
作者
OBrien, JA [1 ]
Nation, RL [1 ]
Evans, AM [1 ]
机构
[1] UNIV S AUSTRALIA, SCH PHARM & MED SCI, ADELAIDE, SA 5000, AUSTRALIA
关键词
D O I
10.1111/j.2042-7158.1996.tb05961.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The rat single-pass isolated perfused liver preparation was used to study the effects of altered perfusate flow rate on the hepatic disposition of morphine and its polar metabolite morphine-3-glucuronide (M3G). Using a balanced, cross-over design, livers of female Sprague-Dawley rats (n = 6) were perfused at 15 and 30 mL min(-1) with erythrocyte- and protein-free perfusion medium containing a constant concentration of morphine (2.7 mu M). After reaching steady-state, inflow and outflow perfusate and bile samples were collected and morphine and M3G were measured by HPLC. Doubling of perfusate flow rate was associated with a significant increase (P < 0.05) in the availability of morphine (mean +/- s.d. of 0.19 +/- 0.06 at 15 mL min(-1) and 0.29 +/- 0.08 at 30 mL min(-1)). The magnitude of the change in morphine availability was consistent with the predictions of the well-stirred model of hepatic elimination. The fate of hepatically generated M3G was assessed by the biliary extraction ratio of M3G; alterations in perfusate flow rate had no significant effect on this ratio (mean +/- s.d. of 0.49 +/- 0.14 at a perfusate flow rate of 15 mi, min(-1) and 0.47 +/- 0.22 at 30 mt min(-1)). A physiologically-based mathematical model, in which the vascular and intracellular spaces of the liver were represented by two well-mixed compartments, was utilized to derive an equation for the biliary extraction ratio of M3G. According to the model, the value of this extraction ratio will become insensitive to changes in perfusate flow rate when the permeability for M3G of the membrane separating the intracellular and vascular compartments is low compared with perfusate flow rate. Hence, the experimental results are consistent with the concept that the hepatic sinusoidal membrane represents a diffusional barrier to M3G.
引用
收藏
页码:498 / 504
页数:7
相关论文
共 50 条
  • [41] Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples
    Skopp, G
    Pötsch, L
    Klingmann, A
    Mattern, R
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2001, 25 (01) : 2 - 7
  • [42] Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice
    Handal, Marte
    Ripel, Ase
    Aasmundstad, Tor
    Skurtveit, Svetlana
    Morland, Jorg
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2007, 86 (03) : 576 - 586
  • [43] BILIARY-EXCRETION OF MORPHINE-3-GLUCURONIDE AND MORPHINE-3-ETHEREAL SULFATE BY DIFFERENT PATHWAYS IN RAT
    PETERSON, RE
    FUJIMOTO, JM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1973, 184 (02): : 409 - 418
  • [44] Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine antinociception in rats
    Baker, L
    Ratka, A
    PAIN, 2002, 95 (1-2) : 65 - 74
  • [45] Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans
    Aasmundstad, TA
    Storset, P
    HUMAN & EXPERIMENTAL TOXICOLOGY, 1998, 17 (06) : 347 - 352
  • [46] Morphine Induces Hyperalgesia without Involvement of µ-Opioid Receptor or Morphine-3-glucuronide
    Maarten Swartjes
    René A. G. Mooren
    Amanda R. Waxman
    Caroline Arout
    Koen van de Wetering
    Jan den Hartigh
    Jos H. Beijnen
    Benjamin Kest
    Albert Dahan
    Molecular Medicine, 2012, 18 : 1320 - 1326
  • [47] Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period
    Abou Hammoud, Hala
    Aymard, Guy
    Lechat, Philippe
    Boccheciampe, Nicolas
    Riou, Bruno
    Aubrun, Frederic
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (04) : 518 - 527
  • [48] PLASMA-CONCENTRATIONS AND RENAL CLEARANCE OF MORPHINE, MORPHINE-3-GLUCURONIDE AND MORPHINE-6-GLUCURONIDE IN CANCER-PATIENTS RECEIVING MORPHINE
    SOMOGYI, AA
    NATION, RL
    OLWENY, C
    TSIRGIOTIS, P
    VANCRUGTEN, J
    MILNE, RW
    CLEARY, JF
    DANZ, C
    BOCHNER, F
    CLINICAL PHARMACOKINETICS, 1993, 24 (05) : 413 - 420
  • [49] Morphine Induces Hyperalgesia without Involvement of μ-Opioid Receptor or Morphine-3-glucuronide
    Swartjes, Maarten
    Mooren, Rene A. G.
    Waxman, Amanda R.
    Arout, Caroline
    van de Wetering, Koen
    den Hartigh, Jan
    Beijnen, Jos H.
    Kest, Benjamin
    Dahan, Albert
    MOLECULAR MEDICINE, 2012, 18 (09) : 1320 - 1326
  • [50] Limited phase I study of morphine-3-glucuronide
    Penson, RT
    Joel, SP
    Clark, S
    Gloyne, A
    Slevin, ML
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (11) : 1810 - 1816